About: Cost per remission and cost per response with infliximab, adalimumab, and golimumab for the treatment of moderately-to-severely active ulcerative colitis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Cost per remission and cost per response with infliximab, adalimumab, and golimumab for the treatment of moderately-to-severely active ulcerative colitis Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 18 February 2015

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в лютому 2015 (uk) scientific article published on 18 February 2015 (en) artículu científicu espublizáu en febreru de 2015 (ast)
publication date	wds:Q86615663-25F6A3C2-6E9B-4341-BCF8-2B4B888B9D85
publication date	2015-02-18 00:00:00Z (xsd:dateTime)
author name string	wds:Q86615663-1BB76031-3CA6-4BFC-9AC6-D5C1C611AB54 wds:Q86615663-8D26509A-0A85-400D-8E93-2A9D9727B30A wds:Q86615663-CF706803-3A42-4DA4-B639-DD298B8CB2D4
author name string	Jeroen P Jansen Eric Druyts Kabirraaj Toor
rdfs:label	Cost per remission and cost per response with infliximab, adalimumab, and golimumab for the treatment of moderately-to-severely active ulcerative colitis (en) Cost per remission and cost per response with infliximab, adalimumab, and golimumab for the treatment of moderately-to-severely active ulcerative colitis (nl)
skos:prefLabel	Cost per remission and cost per response with infliximab, adalimumab, and golimumab for the treatment of moderately-to-severely active ulcerative colitis (en) Cost per remission and cost per response with infliximab, adalimumab, and golimumab for the treatment of moderately-to-severely active ulcerative colitis (nl)
name	Cost per remission and cost per response with infliximab, adalimumab, and golimumab for the treatment of moderately-to-severely active ulcerative colitis (en) Cost per remission and cost per response with infliximab, adalimumab, and golimumab for the treatment of moderately-to-severely active ulcerative colitis (nl)
author	wds:Q86615663-819EC4DB-8865-4F5E-9DBA-5377B912A036
author	Kristian Thorlund
title	wds:Q86615663-134BAD46-6A2A-4324-BAC7-7D97D9344193
title	Cost per remission and cost per response with infliximab, adalimumab, and golimumab for the treatment of moderately-to-severely active ulcerative colitis (en)
page(s)	wds:Q86615663-49442AFF-A9CC-4B5F-91B8-169C21854A4E
page(s)	437-446
instance of	wds:Q86615663-4AC29F9F-8062-4AD3-A044-7AD5C92EF51D
instance of	scholarly article
main subject	wds:Q86615663-46F3D1CB-08C8-4280-AC94-D4160A40BEDC wds:Q86615663-6BB2ABE3-D42D-4629-B6C1-836C82BD9F3A
main subject	ulcerative colitis adalimumab
PubMed ID	wds:Q86615663-0E15B854-932D-444A-A5AC-7285EA48B0FA
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/25629655
PubMed ID	25629655
published in	wds:Q86615663-00950845-9167-4FC8-9523-43211CEF8EDE
published in	Journal of Medical Economics
issue	wds:Q86615663-BC66268A-108D-4914-AF6C-AD15DE99F600
volume	wds:Q86615663-859BFC95-5857-49AB-8021-7FE5698610CE
issue	6
volume	18
DOI	wds:Q86615663-53017E0F-962A-47B4-B061-E73C3F7290F8
DOI	http://dx.doi.org/10.3111/13696998.2015.1012513
DOI	10.3111/13696998.2015.1012513
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q86615663
is cites work of	Cost-effectiveness of biological treatment of ulcerative colitis - a systematic review Recent advances and emerging therapies in the non-surgical management of ulcerative colitis Economic Evaluations of Treatments for Inflammatory Bowel Diseases: A Literature Review. A Systematic Review of the Cost-Effectiveness of Biologics for Ulcerative Colitis. Golimumab in inflammatory bowel diseases: present and future scenarios
is cites work of	wds:Q57170397-17DE43EC-C75A-4031-8ABD-F91B5EFE18B6 wds:Q47278775-8C241242-5C28-4AB3-8ED0-713A7F7DAD4D wds:Q57158320-36FC0270-6998-4A40-BD84-06E2995B248A wds:Q33871726-359DFF50-BC14-4FE2-9A5A-3711FA1289D0 wds:Q55690473-AF12898A-A500-4B2D-96D2-E94A855CA694

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software